DanCann Pharma AS (FRA:DAN) Asset Impairment Charge : €0.00 Mil (TTM As of Sep. 2024)

View and export this data going back to 2021. Start your Free Trial

What is DanCann Pharma AS Asset Impairment Charge?

DanCann Pharma AS's Asset Impairment Charge for the three months ended in Sep. 2024 was €0.00 Mil. Its Asset Impairment Charge for the trailing twelve months (TTM) ended in Sep. 2024 was €0.00 Mil.

DanCann Pharma AS Asset Impairment Charge Historical Data

The historical data trend for DanCann Pharma AS's Asset Impairment Charge can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

DanCann Pharma AS Asset Impairment Charge Chart

DanCann Pharma AS Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Asset Impairment Charge

Get a 7-Day Free Trial

DanCann Pharma AS Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Asset Impairment Charge	Get a 7-Day Free Trial															-	-	-	-	-

DanCann Pharma AS Asset Impairment Charge Calculation

Asset Impairment Charge is the charge against earnings resulting from the aggregate write down of all assets from their carrying value to their fair value.

Asset Impairment Charge for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.00 Mil.

DanCann Pharma AS Asset Impairment Charge Related Terms

Thank you for viewing the detailed overview of DanCann Pharma AS's Asset Impairment Charge provided by GuruFocus.com. Please click on the following links to see related term pages.

DanCann Pharma AS Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » DanCann Pharma AS (FRA:DAN) » Definitions » Asset Impairment Charge

Comparable Companies

Traded in Other Exchanges

DANCAN:Sweden

Address

Rugvaenget 5, Ansager, DNK, DK-6823

Website

https://www.dancann.com

DanCann Pharma AS is a Danish biopharmaceutical Company powered by cannabinoids. DanCann Pharma is a licensed production and distribution Company. The company is focused on discovering, developing, manufacturing, and commercializing novel cannabinoid therapeutics for a broad range of diseases.